---
title: "Elastrin Therapeutics, Inc. SEC filings"
url: https://altstreet.investments/edgar/1848350
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Elastrin Therapeutics, Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | Elastrin Therapeutics, Inc. |
| CIK | 1848350 |
| Filing family | Form D |
| Total offering amount (as filed) | $500,000 |
| Total sold (as reported) | $500,000 |
| Investors (as reported) | 1 |

## Filings (8 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| March 11, 2025 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835025000001/ |
| September 12, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835024000001/ |
| November 3, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835023000004/ |
| November 3, 2023 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835023000002/ |
| September 8, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835023000001/ |
| March 25, 2022 | D | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835022000002/ |
| March 25, 2022 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835022000001/ |
| March 1, 2021 | D | Form D | https://www.sec.gov/Archives/edgar/data/1848350/000184835021000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1848350
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001848350&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1848350
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.